Genetically engineered pig hearts were successfully transplanted into recently deceased humans as part of an effort to create a xenotransplantation protocol for patients with heart disease.
The team of surgeons who performed the investigational procedures observed no early signs of organ rejection over 72 hours. Nader Moazami, MD, surgical director of heart transplantation at the NYU Langone Transplant Institute who led the team, said it was “a milestone and a steppingstone in the right direction.” It was the top story in cardiology last week. Read the full story in Healio.